Mobile

Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval

Update Il y a 4 ans
Reference: NCT00713336

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

This Study compares two ZD4054 (Zibotentan) doses (10mg and 30mg) with a placebo and a positive control to look at ZD4054 (Zibotentan)'s effect on the ECG of Healthy Volunteer

Inclusion criteria

  • Healthy

Links